Michael Dockal

Senior Director
Novo Nordisk
Bagsvaerd, Hovedstaden, Denmark

Presentation(s):

• OC 59.2 - Analyzing Concizumab mechanism of action by a Mathematical Modeling Approach

  Tuesday, June 27, 2023
  15:00 – 15:15 ET

• OC 59.5 - Evaluation of Concizumab in Hemophilia Using Microfluidic Flow Assays

  Tuesday, June 27, 2023
  15:45 – 16:00 ET